Logo image
Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems
Journal article   Peer reviewed

Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems

E. Ingley, R.L. Cutler, M-C FUNG, C.J. Sanderson and I.G. Young
European Journal of Biochemistry, Vol.196(3), pp.623-629
1991
url
Free to Read *No subscription requiredView

Abstract

A cDNA for human interleukin‐5 (hIL‐5) was created from the hIL‐5 gene using site‐directed mutagenesis to splice out the introns in vitro. This cDNA was expressed in yeast and baculovirus systems, utilizing in both cases an in‐frame fusion to the pre sequence of the α‐mating‐type factor to direct secretion. The highest level of production was achieved from Sf9 cells using a baculovirus vector in serum‐containing medium (2.7 mg/l), whereas in serum‐free medium ten times less hIL‐5 was produced. In the yeast system much lower levels of hIL‐5 were produced (12.5 μg/l). Recombinant hIL‐5 was purified to homogeneity from serum‐free baculovirus cultures. The rhIL‐5 consisted of a 30‐kDa homodimer linked by disulfide bridging. The purified recombinant protein had a specific activity on murine BCL1 cells of 1.5x104 U/mg, of 3x105 U/mg in the murine eosinophil differentiation factor assay, and 2.4x107 U/mg in a human peripheral eosinophil maintenance assay.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.65 Allergy
1.65.1177 Eosinophilic Disorders
Web Of Science research areas
Biochemistry & Molecular Biology
ESI research areas
Biology & Biochemistry
Logo image